Constantin Ionel Stefan - Sep 14, 2022 Form 4 Insider Report for Amprius Technologies, Inc. (AMPX)

Role
Chief Technology Officer
Signature
/s/ Sandra Wallach, attorney-in-fact on behalf of Constantin Ionel Stefan
Stock symbol
AMPX
Transactions as of
Sep 14, 2022
Transactions value $
$0
Form type
4
Date filed
9/16/2022, 07:24 PM
Next filing
Dec 15, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPX Stock Option (right to buy) Award +546K 546K Sep 14, 2022 Common Stock 546K $0.05 Direct F1
transaction AMPX Stock Option (right to buy) Award +182K 182K Sep 14, 2022 Common Stock 182K $0.05 Direct F1
transaction AMPX Stock Option (right to buy) Award +72.8K 72.8K Sep 14, 2022 Common Stock 72.8K $0.45 Direct F1
transaction AMPX Stock Option (right to buy) Award +72.8K 72.8K Sep 14, 2022 Common Stock 72.8K $1.78 Direct F1, F2
transaction AMPX Stock Option (right to buy) Award +218K 218K Sep 14, 2022 Common Stock 218K $2.61 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 14, 2022, the Issuer completed a business combination (the "Business Combination") pursuant to the Business Combination Agreement, by and among the Issuer, a wholly owned subsidiary of the Issuer, and Amprius Technologies Operating, Inc. ("Legacy Amprius") At the effective time of the Business Combination (the "Effective Time"), each Legacy Amprius option was converted into an option to purchase a number of shares of Common Stock of the Issuer equal to the product (rounded down to the nearest whole number) of (i) the number of shares of Legacy Amprius common stock subject to the Legacy Amprius option immediately prior to the Effective Time multiplied by (ii) an exchange ratio of approximately 1.45590, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such Legacy Amprius option immediately prior to the Effective Time divided by (B) the Exchange Ratio.
F2 1/48 of the total number of shares issuable upon exercise of the option vested on July 17, 2021, and 1/48 of the total number of shares issuable upon exercise of the option vest monthly thereafter until fully vested on June 17, 2025.
F3 1/48 of the total number of shares issuable upon exercise of the option vested on February 1, 2023, and 1/48 of the total number of shares issuable upon exercise of the option vest monthly thereafter until fully vested on January 1, 2027.